8-K: QT Imaging Secures Exclusive Saudi Arabia Distribution Deal

QT Imaging Holdings, Inc. has signed an exclusive distribution agreement with Gulf Medical Co. for its breast imaging technology in Saudi Arabia, projecting over $33 million in revenue.

Summary

• QT Imaging Holdings, Inc. (QTIH) entered into an exclusive Distribution Agreement with Gulf Medical Co. (GMC) on August 21, 2025.
• GMC will be the exclusive distributor of QT Breast Acoustic CT Scanners and QTI Cloud Platform SaaS subscriptions in Saudi Arabia.
• The initial term of the agreement is three years, from August 21, 2025, to August 21, 2028, with a potential one-year extension if minimum purchase requirements are met.
• The agreement mandates minimum order quantities of five scanners per quarter, starting in Q1 2026, through the end of 2028, totaling at least 60 scanners.
• This is projected to generate over $33 million in revenue for QT Imaging Holdings over the three-year period.
• GMC is responsible for marketing, sales, customer support, and securing all necessary governmental approvals, including acting as QTIH's Authorized Representative before the Saudi Food and Drug Authority (SFDA).
• QTIH will provide training and professional services to GMC and retains all intellectual property rights.
• Approved Products include the QT Scanner 2000 Model B, with prices ranging from $560,000 (1-year warranty) to $728,000 (5-year warranty), and QTI Cloud Platform SaaS tiers (Essentials, Pro, Enterprise) with monthly/annual pricing.
• Payment terms require 50% upon order placement and 50% within 45 days of shipping, or an irrevocable letter of credit for certain orders, all in United States Dollars.

Sentiment

Score: 8

Explanation: The filing announces a significant exclusive distribution agreement with clear revenue projections, addressing a specific market need with innovative technology. This represents a strong positive step for the company's commercialization strategy and future growth, despite inherent risks in market entry and execution.

Positives

• Secured an exclusive distribution agreement for Saudi Arabia, a significant market for breast imaging technology.
• Guaranteed minimum order quantities of 60 scanners over three years, projecting over $33 million in revenue.
• Partnership with Gulf Medical Co., a well-established distributor with a proven track record in introducing advanced medical technologies in the Middle East.
• The QTI Breast Acoustic CT scanner's non-invasive nature (no compression, contrast, or ionizing radiation) is well-suited for the Saudi Arabian market, where there is a high prevalence of breast cancer among younger women and genetic predispositions.
• Expansion of the QTI Cloud Platform with AI-driven tools is expected to enhance breast health through imaging intelligence and provide recurring SaaS revenue.

Negatives

• Specific minimum purchase requirements for each year of the initial term are not publicly disclosed in the filing, only a general note about 'not less than 5 QTI Breast Acoustic CT Scanners per quarter' after SFDA approval and commercial activities.
• The agreement's automatic extension is contingent on GMC meeting minimum purchase requirements, introducing a performance-based risk for continued exclusivity.
• GMC is responsible for securing all governmental approvals and customs clearances, which could introduce delays or complexities in market entry.

Risks

• Research results from the use of the QT Imaging Breast Acoustic CT Scanner and clinical studies may not meet expectations.
• Ability to sell and deploy the QT Imaging Breast Acoustic CT Scanner in the Territory may be hindered by unforeseen challenges.
• Regulatory matters in Saudi Arabia, including obtaining and maintaining necessary licenses from the SFDA, could impact market entry and operations.
• Ability to extend product offerings into new areas or products may not materialize as planned.
• Challenges in commercializing the technology, including market acceptance and competition.
• Unexpected occurrences that deter the full documentation and bring-to-market plan for products.
• Trends and fluctuations in the industry, changes in demand and purchasing volume of customers, and unpredictability of suppliers.
• Ability to attract and retain qualified personnel for both QTIH and GMC to support the distribution efforts.
• Ability to move product sales to production levels to meet demand.

Future Outlook

The company expects to significantly expand its market presence and revenue through the exclusive distribution of its QT Breast Acoustic CT imaging technology and QTI Cloud Platform in Saudi Arabia. The agreement outlines minimum purchase requirements designed to generate over $33 million in revenue over three years, starting in Q1 2026. The QTI Cloud Platform is anticipated to transform breast health through imaging intelligence with AI-driven tools.

Management Comments

• "Successfully marketing and distributing an innovative technology like the QTI Breast Acoustic CT scanner requires a deep understanding of regional market dynamics and the specific needs of clinicians and patients."
• "With GMCs proven track record in introducing advanced medical technologies, we are confident they are the ideal partner."

Industry Context

The agreement positions QT Imaging Holdings to address a critical need in Saudi Arabia, where breast cancer incidence is high, particularly among younger women (40-59 years) and those with genetic predispositions like BRCA1 and BRCA2 mutations. The non-invasive nature of the QTI Breast Acoustic CT scanner, which avoids compression, contrast, and ionizing radiation, offers a suitable solution for early detection and screening initiatives in this demographic, aligning with the region's specific healthcare challenges and patient preferences.

Comparison to Industry Standards

• NA

Stakeholder Impact

• **Shareholders**: Positive impact due to projected revenue growth, market expansion, and validation of the company's technology in a new, significant market.
• **Customers (in Saudi Arabia)**: Increased access to a non-invasive breast imaging technology, potentially leading to improved early detection and health outcomes.
• **Employees**: Potential for increased workload and hiring in areas supporting international distribution, training, and manufacturing.
• **Partners (Gulf Medical Co.)**: Significant business opportunity as the exclusive distributor of innovative medical technology in Saudi Arabia.

Next Steps

• GMC will submit the agreement to the Saudi Ministry of Trade to acquire an Agency certificate.
• GMC will secure all required governmental approvals, permits, licenses, customs clearances, and authorizations for Approved Products in Saudi Arabia.
• QTIH will provide training and professional services to GMC.
• GMC will begin purchasing Approved Products with minimum order quantities of five scanners per quarter starting in Q1 2026.
• The parties will monitor GMC's performance against Minimum Purchase Requirements for potential agreement extension.

Key Dates

Recommendation

The exclusive distribution agreement with Gulf Medical Co. in Saudi Arabia represents a substantial positive development for QT Imaging Holdings. The projected minimum revenue of over $33 million over three years, coupled with the strategic entry into a high-need market for breast cancer screening, provides a clear growth trajectory. The non-invasive nature of the technology is well-suited for the regional demographic, and partnering with an established distributor mitigates some market entry risks. While execution risks remain, the quantifiable revenue commitment and market expansion potential make this a strong buy signal for long-term investors.

Keywords

QT Imaging Holdings, Gulf Medical Co., Saudi Arabia, Distribution Agreement, Breast Acoustic CT Scanner, QTI Cloud Platform, Medical Device, Exclusive Distributor, Healthcare Technology, SaaS, Breast Cancer Screening